Antiviral research

Keyphrases

Publications

volume 230, 2024

Michael O Okpara, Frederick Weaver, Adrian Whitehouse, Clinton G L Veale, Adrienne L Edkins
Discovery of a small-molecule inhibitor of KSHV lytic replication from the MMV pandemic response box. Antiviral research 230 (2024)
Yu Cong, Saurabh Dixit, Donna L Perry, Louis M Huzella, Erin Kollins, Russell Byrum, Scott M Anthony, David Drawbaugh, Sanae Lembirik, Elena Postnikova, Brett Eaton, Michael Murphy, Gregory Kocher, Kyra Hadley, Anthony E Marketon, Rebecca M Bernbaum, Amanda M W Hischak, Randy Hart, Nick Vaughan, Jiro Wada, Jing Qin, Marisa C St Claire, Connie S Schmaljohn, Michael R Holbrook
Characterization of therapeutic antibody efficacy against multiple SARS-CoV-2 variants in the hamster model. Antiviral research 230 (2024)
Kaiming Tao, Jinru Zhou, Pavithra Nagarajan, Philip L Tzou, Robert W Shafer
Comprehensive database of HIV mutations selected during antiretroviral in vitro passage experiments. Antiviral research 230 (2024)
Zsuzsa K Szemere, Eain A Murphy
Import of extracellular 2'-3'cGAMP by the folate transporter, SLC19A1, establishes an antiviral response that limits herpes simplex virus-1. Antiviral research 230 (2024)
Li He, Laura Hertel, Claire D James, Iain M Morgan, Aloysius J Klingelhutz, Tong-Ming Fu, Lawrence M Kauvar, Michael A McVoy
Inhibition of human cytomegalovirus entry into mucosal epithelial cells. Antiviral research 230 (2024)
Zirong Han, Qianyi Mai, Yangguo Zhao, Xinglai Liu, Mingting Cui, Minchao Li, Yaoqing Chen, Yuelong Shu, Jianhui Gan, Weiqi Pan, Caijun Sun
Mosaic neuraminidase-based vaccine induces antigen-specific T cell responses against homologous and heterologous influenza viruses. Antiviral research 230 (2024)
Guofu Ye, Chengcong Chen, Yongjun Zhou, Libo Tang, Jianzhong Cai, Yiyan Huang, Jiayue Yang, Yaoting Feng, Liangxing Chen, Yuhao Wang, Yanchen Ma, Guanfeng Lin, Yingsong Wu, Xiaotao Jiang, Jinlin Hou, Yongyin Li
Anti-HBc mirrors the activation of HBV-specific CD8 + T cell immune response and exhibits a direct effect on HBV control. Antiviral research 230 (2024)
Patrick T Keiser, Wenhan Zhang, Michael Ricca, Alan Wacquiez, Autumn Grimins, Regina Cencic, J J Patten, Pranav Shah, Elias Padilha, John H Connor, Jerry Pelletier, Shawn M Lyons, Mohsan Saeed, Lauren E Brown, John A Porco, Robert A Davey
Amidino-rocaglates (ADRs), a class of synthetic rocaglates, are potent inhibitors of SARS-CoV-2 replication through inhibition of viral protein synthesis. Antiviral research 230 (2024)
Romel Rosales, Briana L McGovern, M Luis Rodriguez, Rocio Leiva-Rebollo, Randy Diaz-Tapia, Jared Benjamin, Devendra K Rai, Rhonda D Cardin, Annaliesa S Anderson, null null, Emilia Mia Sordillo, Harm van Bakel, Viviana Simon, Adolfo García-Sastre, Kris M White
Nirmatrelvir and molnupiravir maintain potent in vitro and in vivo antiviral activity against circulating SARS-CoV-2 omicron subvariants. Antiviral research 230 (2024)
Keon-Woong Yoon, Ki Back Chu, Gi-Deok Eom, Jie Mao, Sung Soo Kim, Fu-Shi Quan
Orally dissolving film as a potential vaccine delivery carrier to prevent influenza virus infection. Antiviral research 230 (2024)
Anna Bonomini, Jiwei Zhang, Han Ju, Alessia Zago, Martina Pacetti, Oriana Tabarrini, Serena Massari, Xinyong Liu, Beatrice Mercorelli, Peng Zhan, Arianna Loregian
Synergistic activity of an RNA polymerase PA-PB1 interaction inhibitor with oseltamivir against human and avian influenza viruses in cell culture and in ovo. Antiviral research 230 (2024)
Masako Yamasaki, Wakana Saso, Takuya Yamamoto, Masayoshi Sato, Hiroko Takagi, Tetsuya Hasegawa, Yuji Kozakura, Hiroyuki Yokoi, Hirofumi Ohashi, Kana Tsuchimoto, Rina Hashimoto, Shuetsu Fukushi, Akihiko Uda, Masamichi Muramatsu, Kazuo Takayama, Ken Maeda, Yoshimasa Takahashi, Tsuyoshi Nagase, Koichi Watashi
Anti-SARS-CoV-2 gapmer antisense oligonucleotides targeting the main protease region of viral RNA. Antiviral research 230 (2024)
Entao Li, Qizan Gong, Jiachen Zhang, Xiaoping Guo, Wenyu Xie, Da Chen, Yanqiong Shen, Dongxiang Hong, Zhihao Li, Qianqian Wang, Chao Wang, Yucai Wang, Sandra Chiu
An mpox quadrivalent mRNA vaccine protects mice from lethal vaccinia virus challenge. Antiviral research 230 (2024)

volume 229, 2024

Ernna H Oliveira, Ana C Monteleone-Cassiano, Lucas Tavares, Jadson C Santos, Thais M Lima, Giovanni F Gomes, Pedro P Tanaka, Cintia J Monteiro, Matheus Munuera, Sabrina S Batah, Alexandre T Fabro, Vitor M Faça, Ana P Masson, Eduardo A Donadi, Mariangela Dametto, Rodrigo Bonacin, Ronaldo B Martins, Eurico Arruda Neto, Luis Lamberti P daSilva, Thiago M Cunha, Geraldo A Passos
A mimetic peptide of ACE2 protects against SARS-CoV-2 infection and decreases pulmonary inflammation related to COVID-19. Antiviral research 229 (2024)
Dongdong Chen, Wen Su, Ka-Tim Choy, Yan Sing Chu, Chi Ho Lin, Hui-Ling Yen
High throughput profiling identified PA-L106R amino acid substitution in A(H1N1)pdm09 influenza virus that confers reduced susceptibility to baloxavir in vitro. Antiviral research 229 (2024)
Brecht Bonneux, Edgar Jacoby, Martina Ceconi, Kim Stobbelaar, Peter Delputte, Florence Herschke
Direct-acting antivirals for RSV treatment, a review. Antiviral research 229 (2024)
Dongdong Chen, Wen Su, Ka-Tim Choy, Yan Sing Chu, Chi Ho Lin, Hui-Ling Yen
High throughput profiling identified PA-L106R amino acid substitution in A(H1N1)pdm09 influenza virus that confers reduced susceptibility to baloxavir in vitro. Antiviral research 229 (2024)
Kei Konishi, Shinji Kusakabe, Nijiho Kawaguchi, Takao Shishido, Naoto Ito, Michiko Harada, Satoshi Inoue, Ken Maeda, William W Hall, Yasuko Orba, Hirofumi Sawa, Michihito Sasaki, Akihiko Sato
β-d-N 4 -hydroxycytidine, a metabolite of molnupiravir, exhibits in vitro antiviral activity against rabies virus. Antiviral research 229 (2024)
Konstantin Andreev, Jeremy C Jones, Patrick Seiler, Ahmed Kandeil, Richard J Webby, Elena A Govorkova
Genotypic and phenotypic susceptibility of emerging avian influenza A viruses to neuraminidase and cap-dependent endonuclease inhibitors. Antiviral research 229 (2024)
Konstantin Andreev, Jeremy C Jones, Patrick Seiler, Ahmed Kandeil, Richard J Webby, Elena A Govorkova
Genotypic and phenotypic susceptibility of emerging avian influenza A viruses to neuraminidase and cap-dependent endonuclease inhibitors. Antiviral research 229 (2024)
Zhe Xie, Ulrike Protzer
Activating adaptive immunity by bispecific, T-cell engager antibodies bridging infected and immune-effector cells is a promising novel therapy for chronic hepatitis B. Antiviral research 229 (2024)
Yongru Xu, Fang Sun, Zhengran Chuai, Junyun Wang, Zhifang Bai, Chengrong Bian, Xiliang Wang, Zhongpeng Zhao, Yongzhuang Liu, Penghui Yang
Cold-adapted influenza vaccine carrying three repeats of a respiratory syncytial virus (RSV) fusion glycoprotein epitope site protects BALB/c mice and cotton rats against RSV infection. Antiviral research 229 (2024)
Jonna B Westover, Kevin W Bailey, Samantha R Wasson, Kirsten M Boardman, Kurt H Lustig, Sean M Amberg, Brian B Gowen
Coadministration of LHF-535 and favipiravir protects against experimental Junín virus infection and disease. Antiviral research 229 (2024)
David Wensel, Margaret Gartland, Jagadish Beloor, Kartika N Shetty, Jana Wolf, Eugene Stewart, Andrew Clark, Allan Tenorio, Mark Krystal
The sensitivity of HIV-1 gp120 polymorphs to inhibition by temsavir correlates to temsavir binding on-rate. Antiviral research 229 (2024)
Jia Ji, Taoming Tang, Miaojin Zhu, Zhigang Wu, Jiale Zhang, Danrong Shi, Linwei Zhu, Xiaodi Zhang, Xiangyun Lu, Lei Chen, Hangping Yao
Boosting the immune response in COVID-19 vaccines via an Alum:CpG complex adjuvant. Antiviral research 229 (2024)
Jonna B Westover, Kevin W Bailey, Samantha R Wasson, Kirsten M Boardman, Kurt H Lustig, Sean M Amberg, Brian B Gowen
Coadministration of LHF-535 and favipiravir protects against experimental Junín virus infection and disease. Antiviral research 229 (2024)
Brecht Bonneux, Edgar Jacoby, Martina Ceconi, Kim Stobbelaar, Peter Delputte, Florence Herschke
Direct-acting antivirals for RSV treatment, a review. Antiviral research 229 (2024)
Irina Chon, Keita Wagatsuma, Reiko Saito, Julian W Tang, Sato Isamu, Eitaro Suzuki, Yutaka Shirahige, Takashi Kawashima, Michiyoshi Minato, Naoki Kodo, Hironori Masaki, Hirotsune Hamabata, Sayaka Yoshioka, Yusuke Ichikawa, Yuyang Sun, Jiaming Li, Teruhime Otoguto, Hisami Watanabe
Detection of influenza A(H3N2) viruses with polymerase acidic subunit substitutions after and prior to baloxavir marboxil treatment during the 2022-2023 influenza season in Japan. Antiviral research 229 (2024)
Zhe Xie, Ulrike Protzer
Activating adaptive immunity by bispecific, T-cell engager antibodies bridging infected and immune-effector cells is a promising novel therapy for chronic hepatitis B. Antiviral research 229 (2024)
Kei Konishi, Shinji Kusakabe, Nijiho Kawaguchi, Takao Shishido, Naoto Ito, Michiko Harada, Satoshi Inoue, Ken Maeda, William W Hall, Yasuko Orba, Hirofumi Sawa, Michihito Sasaki, Akihiko Sato
β-d-N 4 -hydroxycytidine, a metabolite of molnupiravir, exhibits in vitro antiviral activity against rabies virus. Antiviral research 229 (2024)
Ernna H Oliveira, Ana C Monteleone-Cassiano, Lucas Tavares, Jadson C Santos, Thais M Lima, Giovanni F Gomes, Pedro P Tanaka, Cintia J Monteiro, Matheus Munuera, Sabrina S Batah, Alexandre T Fabro, Vitor M Faça, Ana P Masson, Eduardo A Donadi, Mariangela Dametto, Rodrigo Bonacin, Ronaldo B Martins, Eurico Arruda Neto, Luis Lamberti P daSilva, Thiago M Cunha, Geraldo A Passos
A mimetic peptide of ACE2 protects against SARS-CoV-2 infection and decreases pulmonary inflammation related to COVID-19. Antiviral research 229 (2024)
Yongru Xu, Fang Sun, Zhengran Chuai, Junyun Wang, Zhifang Bai, Chengrong Bian, Xiliang Wang, Zhongpeng Zhao, Yongzhuang Liu, Penghui Yang
Cold-adapted influenza vaccine carrying three repeats of a respiratory syncytial virus (RSV) fusion glycoprotein epitope site protects BALB/c mice and cotton rats against RSV infection. Antiviral research 229 (2024)
Hiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi, Masaya Yamato, Akimasa Fukushi, Takumi Imamura, Hiroki Sakaguchi, Takuhiro Sonoyama, Takao Sanaki, Genki Ichihashi, Yuko Tsuge, Takeki Uehara, Hiroshi Mukae
Prevention of post COVID-19 condition by early treatment with ensitrelvir in the phase 3 SCORPIO-SR trial. Antiviral research 229 (2024)
Jia Ji, Taoming Tang, Miaojin Zhu, Zhigang Wu, Jiale Zhang, Danrong Shi, Linwei Zhu, Xiaodi Zhang, Xiangyun Lu, Lei Chen, Hangping Yao
Boosting the immune response in COVID-19 vaccines via an Alum:CpG complex adjuvant. Antiviral research 229 (2024)
Jonna B Westover, Kevin W Bailey, Samantha R Wasson, Kirsten M Boardman, Kurt H Lustig, Sean M Amberg, Brian B Gowen
Coadministration of LHF-535 and favipiravir protects against experimental Junín virus infection and disease. Antiviral research 229 (2024)
Hiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi, Masaya Yamato, Akimasa Fukushi, Takumi Imamura, Hiroki Sakaguchi, Takuhiro Sonoyama, Takao Sanaki, Genki Ichihashi, Yuko Tsuge, Takeki Uehara, Hiroshi Mukae
Prevention of post COVID-19 condition by early treatment with ensitrelvir in the phase 3 SCORPIO-SR trial. Antiviral research 229 (2024)
Yongru Xu, Fang Sun, Zhengran Chuai, Junyun Wang, Zhifang Bai, Chengrong Bian, Xiliang Wang, Zhongpeng Zhao, Yongzhuang Liu, Penghui Yang
Cold-adapted influenza vaccine carrying three repeats of a respiratory syncytial virus (RSV) fusion glycoprotein epitope site protects BALB/c mice and cotton rats against RSV infection. Antiviral research 229 (2024)
Irina Chon, Keita Wagatsuma, Reiko Saito, Julian W Tang, Sato Isamu, Eitaro Suzuki, Yutaka Shirahige, Takashi Kawashima, Michiyoshi Minato, Naoki Kodo, Hironori Masaki, Hirotsune Hamabata, Sayaka Yoshioka, Yusuke Ichikawa, Yuyang Sun, Jiaming Li, Teruhime Otoguto, Hisami Watanabe
Detection of influenza A(H3N2) viruses with polymerase acidic subunit substitutions after and prior to baloxavir marboxil treatment during the 2022-2023 influenza season in Japan. Antiviral research 229 (2024)
David Wensel, Margaret Gartland, Jagadish Beloor, Kartika N Shetty, Jana Wolf, Eugene Stewart, Andrew Clark, Allan Tenorio, Mark Krystal
The sensitivity of HIV-1 gp120 polymorphs to inhibition by temsavir correlates to temsavir binding on-rate. Antiviral research 229 (2024)

volume 228, 2024

Agnieszka Baliga-Gil, Marta Soszynska-Jozwiak, Agnieszka Ruszkowska, Izabela Szczesniak, Ryszard Kierzek, Maria Ciechanowska, Magdalena Trybus, Paulina Jackowiak, Jake M Peterson, Walter N Moss, Elzbieta Kierzek
Targeting sgRNA N secondary structure as a way of inhibiting SARS-CoV-2 replication. Antiviral research 228 (2024)
Tai-Wei Li, Youngmin Park, Emily G Watters, Xu Wang, Dawei Zhou, Guillaume N Fiches, Zhenyu Wu, Andrew D Badley, Jonah B Sacha, Wen-Zhe Ho, Netty G Santoso, Jun Qi, Jian Zhu
KDM5A/B contribute to HIV-1 latent infection and survival of HIV-1 infected cells. Antiviral research 228 (2024)
Jane A Potter, Angus Aitken, Lei Yang, Jennifer Hill, Antoni Tortajada, Julia L Hurwitz, Bart G Jones, Nadiawati Alias, Mingkui Zhou, Helen Connaris
HEX17(Neumifil): An intranasal respiratory biotherapeutic with broad-acting antiviral activity. Antiviral research 228 (2024)
Yuan Wen, Shuyue Deng, Tianmin Wang, Mengtian Gao, Wenlong Nan, Fang Tang, Qinghong Xue, Yanmin Ju, Jianjun Dai, Yurong Wei, Feng Xue
Novel strategy for Poxviridae prevention: Thermostable combined subunit vaccine patch with intense immune response. Antiviral research 228 (2024)
Alison Daniels, Monikaben Padariya, Sarah Fletcher, Kathryn Ball, Ashita Singh, Neil Carragher, Ted Hupp, Christine Tait-Burkard, Umesh Kalathiya
Molecules targeting a novel homotrimer cavity of Spike protein attenuate replication of SARS-CoV-2. Antiviral research 228 (2024)
Xin Liu, Miao Zheng, Hongqing Zhang, Bo Feng, Jiaqi Li, Yanan Zhang, Ji Zhang, Na Zhao, Chaoqiang Li, Ning Song, Bin Song, Dongyuan Yang, Jin Chen, Ao Qi, Linxiang Zhao, Cheng Luo, Yi Zang, Hong Liu, Jia Li, Bo Zhang, Yu Zhou, Jie Zheng
Characterization and noncovalent inhibition of the K63-deubiquitinase activity of SARS-cov-2 PLpro. Antiviral research 228 (2024)
Eva Ogire, Laure Perrin-Cocon, Marianne Figl, Cindy Kundlacz, Clémence Jacquemin, Sophie Hubert, Anne Aublin-Gex, Johan Toesca, Christophe Ramière, Pierre-Olivier Vidalain, Cyrille Mathieu, Vincent Lotteau, Olivier Diaz
Dengue Virus dependence on glucokinase activity and glycolysis Confers Sensitivity to NAD(H) biosynthesis inhibitors. Antiviral research 228 (2024)
Thayne H Dickey, Nichole D Salinas, Palak Patel, Sachy Orr-Gonzalez, Tarik Ouahes, Holly McAleese, Brandi L Richardson, Myesha Singleton, Michael Murphy, Brett Eaton, Jennifer L Kwan, Michael R Holbrook, Lynn E Lambert, Niraj H Tolia
RBD design increases the functional antibody titers elicited by SARS-CoV-2 spike vaccination. Antiviral research 228 (2024)
Jiawei Pei, Ye Tian, Yamei Dang, Wei Ye, Xiaoqian Liu, Ningbo Zhao, Jiangfan Han, Yongheng Yang, Ziqing Zhou, Xudong Zhu, Hao Zhang, Arshad Ali, Yu Li, Fanglin Zhang, Yingfeng Lei, Airong Qian
Flexible nano-liposomes-encapsulated recombinant UL8-siRNA (r/si-UL8) based on bioengineering strategy inhibits herpes simplex virus-1 infection. Antiviral research 228 (2024)
Kerstin K Schwickert, Mirco Glitscher, Daniela Bender, Nuka Ivalu Benz, Robin Murra, Kevin Schwickert, Steffen Pfalzgraf, Tanja Schirmeister, Ute A Hellmich, Eberhard Hildt
Zika virus replication is impaired by a selective agonist of the TRPML2 ion channel. Antiviral research 228 (2024)
Yuyang Sun, Keita Wagatsuma, Reiko Saito, Isamu Sato, Takashi Kawashima, Tadashi Saito, Yashushi Shimada, Yasuhiko Ono, Fujio Kakuya, Michiyoshi Minato, Naoki Kodo, Eitaro Suzuki, Akito Kitano, Irina Chon, Wint Wint Phyu, Jiaming Li, Hisami Watanabe
Duration of fever in children infected with influenza A(H1N1)pdm09, A(H3N2) or B virus and treated with baloxavir marboxil, oseltamivir, laninamivir, or zanamivir in Japan during the 2012-2013 and 2019-2020 influenza seasons. Antiviral research 228 (2024)